Litigation Details for Nuvasive, Inc. v. Alphatec Holdings, Inc. (S.D. Cal. 2018)
✉ Email this page to a colleague
Nuvasive, Inc. v. Alphatec Holdings, Inc. (S.D. Cal. 2018)
Docket | ⤷ Try a Trial | Date Filed | 2018-02-13 |
Court | District Court, S.D. California | Date Terminated | |
Cause | 35:0271 Patent Infringement | Assigned To | Cathy Ann Bencivengo |
Jury Demand | Plaintiff | Referred To | Mitchell D. Dembin |
Patents | 10,251,778; 10,314,859; 10,463,598; 6,383,509; 6,620,859; 6,974,833; 7,108,974; 7,575,924; 7,579,439; 7,691,598; 7,833,525; 7,867,780; 7,875,260; 7,985,147; 8,147,752; 8,261,833; 8,383,778; 8,579,869; 8,626,531; 8,691,831; 8,691,833; 8,691,938; 8,703,780; 8,801,955; 8,859,575; 8,859,832; 9,227,924; 9,579,270; 9,700,531; 9,801,581; 9,867,793; 9,867,833; 9,974,753; 9,974,793; 9,995,752; 9,995,753 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Nuvasive, Inc. v. Alphatec Holdings, Inc.
Biologic Drugs cited in Nuvasive, Inc. v. Alphatec Holdings, Inc.
The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for Nuvasive, Inc. v. Alphatec Holdings, Inc. (S.D. Cal. 2018)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2020-04-10 | 281 | Order on Motion for Summary Judgment | 9,833,227; U.S. Patent No. 8,753,270; U.S. Patent No. 9,924,859; and U.S. Patent No. 9,974,531. 28…of the ‘832 patent, claims 21, 22, 24 and 16 27 of the ‘780 patent, and claims 1, 2, 3, 6 and 12 of the…device. Id. at 1362. 6 A. The ‘832 Patent 7 The ‘832 patent is for a “Surgical… is GRANTED IN PART and DENIED 6 IN PART. 7 The patents-at-issue generally claim a surgical…patient. [Doc. No. 1-12 at Col. 3:1-6.] The claims of the ‘270 patent | External link to document |
2020-04-24 | 282 | Order on Motion for Summary Judgment | ‘227, ‘270 and ‘531 patents, and Brian Snider, an inventor of the ‘859 patent, 10 and therefore should… No. 1-12]; U.S. Patent No. 9,924,859 [Doc. No. 110-44]; and U.S. Patent No. 9,974,531 [Doc. No. 110- …of the surgical access system claimed in the ‘859 patent 5 includes the limitation of 6 a …summary judgment of non- 3 infringement of the ‘859 patent for failure to meet this claim limitation is …,832 [Doc. No. 1-8]; U.S. Patent No. 9,833,227 [Doc. No. 1-10]; U.S. Patent No. 8,753,270 [Doc. No | External link to document |
2020-04-30 | 284 | Order on Motion to Exclude | 17 Warsaw Orthopedics, Inc. v. NuVasive, Inc., 778 F.3d 1365, 1375 (Fed. Cir. 2015). 18 Alphatec contends… Alphatec's Motion to Exclude Experts [Doc. No. 251 ]. Signed by Judge Cathy Ann Bencivengo on 4/30/2020… Defendants. [Doc. No. 251] 15 16 17 Before the Court is Alphatec’s … testimony of NuVasive’s 18 experts. [Doc. No. 251.] NuVasive filed an opposition. [Doc. No. 259.] Alphatec…the nonobviousness the patents-at-issue. Dr. Youssef opines that the 4 patented inventions are embodied | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |